Atractyl<wbr/>enolide III

Atractylenolide III

CAT N°: 24911
Price:

From 85.00 72.25

Atractylenolide III is a sesquiterpene that has been isolated from Atractylodes and has diverse biological activities, including anti-inflammatory, anti-angiogenic, pro- and anti-apoptotic, and neuroprotective properties.{37638,37639,37640,37641,37642} It inhibits the release of nitric oxide (NO), prostaglandin E2 (PGE2; Item No. 14010), TNF-?, and IL-6 induced by LPS from RAW264.7 macrophages when used at a concentration of 50 µM.{37638} Atractylenolide III (100 µM) induces apoptosis and cell cycle arrest, as well as increases caspase-3, caspase-9, and poly(ADP-ribose) polymerase (PARP) cleavage in A549 human lung carcinoma cells.{37640} However, in primary embryonic mouse cerebral cortical neurons, it inhibits glutamate-induced apoptosis and DNA fragmentation when used at a concentration of 40 µM.{37641} It inhibits angiogenesis in an MDA-MB-231 human breast cancer mouse xenograft model when administered at a dose of 25 mg/kg per day.{37639} Atractylenolide III (0.6 mg/kg per day) also decreases the latency to find the platform in the Morris water maze in a rat model of learning deficits induced by high-dose homocysteine.{37642}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (4aS,8aR,9aS)-4a,5,6,7,8,8a,9,9a-octahydro-9a-hydroxy-3,8a-dimethyl-5-methylene-naphtho[2,3-b]furan-2(4H)-one
  • Correlated keywords
    • 8?-Hydroxyasterolide Hydroxy asterolide ATL-III ATLIII antiinflammatory antiangiogenic proapoptotic antiapoptotic PGE-2 TNF? IL6 lipopolysaccharide RAW-264.7 A-549 MDAMB231 Neuro protective
  • Product Overview:
    Atractylenolide III is a sesquiterpene that has been isolated from Atractylodes and has diverse biological activities, including anti-inflammatory, anti-angiogenic, pro- and anti-apoptotic, and neuroprotective properties.{37638,37639,37640,37641,37642} It inhibits the release of nitric oxide (NO), prostaglandin E2 (PGE2; Item No. 14010), TNF-?, and IL-6 induced by LPS from RAW264.7 macrophages when used at a concentration of 50 µM.{37638} Atractylenolide III (100 µM) induces apoptosis and cell cycle arrest, as well as increases caspase-3, caspase-9, and poly(ADP-ribose) polymerase (PARP) cleavage in A549 human lung carcinoma cells.{37640} However, in primary embryonic mouse cerebral cortical neurons, it inhibits glutamate-induced apoptosis and DNA fragmentation when used at a concentration of 40 µM.{37641} It inhibits angiogenesis in an MDA-MB-231 human breast cancer mouse xenograft model when administered at a dose of 25 mg/kg per day.{37639} Atractylenolide III (0.6 mg/kg per day) also decreases the latency to find the platform in the Morris water maze in a rat model of learning deficits induced by high-dose homocysteine.{37642}

We also advise you